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Abstract
Background: To determine the usefulness of ultrasonography in the assessment of post radiotherapy skin changes
in postmastectomy breast cancer patients.
Methods: Patients treated for postmastectomy radiotherapy in National University Hospital (NUH) and Tan Tock
Seng Hospital (TTSH), Singapore between January 2004- December 2005 was recruited retrospectively. Ultrasound
scan was performed on these Asian patients who had been treated to a total dose of 46-50 Gy with 1 cm bolus
placed on the skin. The ultrasound scans were performed blinded to the RTOG scores, and the skin thickness of
the individually marked points on the irradiated chest wall was compared to the corresponding points on the non-
irradiated breast.
Results: The mean total skin thickness inclusive of the epidermis and the dermis of the right irradiated chest wall
was 0.1712 mm (± 0.03392 mm) compared with the contra-lateral non-irradiated breast which was 0.1845 mm (±
0.04089 mm; p = 0.007). The left irradiated chest wall had a mean skin thickness of 0.1764 mm (± 0.03184 mm)
compared with the right non-irradiated breast which was 0.1835 mm (± 0.02584 mm; p = 0.025). These
independent t-tests produced a significant difference of reduced skin thickness on the right irradiated chest wall,
p = 0.007 (p < 0.05) and left irradiated chest wall p = 0.025 (p < 0.025) in comparison to the non-irradiated skin
thickness investigating chronic skin reactions. Patients with grade 2 acute skin toxicity presented with thinner skin
as compared to patients with grade 1 (p = 0.006).
Conclusions: This study has shown that there is a statistically significant difference between the skin thicknesses of
the irradiated chest wall and the contra-lateral non-irradiated breast and a predisposition to chronic reactions was
found in patients with acute RTOG scoring of grade1 and grade 2.
Introduction
Breast cancer is the most commonly diagnosed cancer
and the leading cause of cancer deaths among women
worldwide [1]. In addition to the acknowledged
advances in surgical and medical therapies, the role of
radiotherapy continues to remain important for all
stages of breast cancer. While its role as adjuvant ther-
apy in selected patients undergoing mastectomy for
stages I and II disease is currently evolving, it has how-
ever, become an essential component of the combined
modality approach for stage III disease. Postmastectomy
radiotherapy (PMRT) to the chest wall and to the regio-
nal lymphatics has shown to decrease locoregional
recurrence and increase survival for women with large
tumors and/or node-positive disease [2-5]. These studies
showed that PMRT not only reduced local regional
recurrence rates but also improved disease free and
overall survival rates in premenopausal patients receiv-
ing chemotherapy.
In spite of the advances in radiotherapy techniques,
early and late adverse effects after breast irradiation are
reported in a range of organs and tissues. Some of these
adverse effects include ischemic heart disease, pneumo-
nities and pulmonary fibrosis, erythema, telangiectasia
and ulceration of the skin [6,7] with skin being the most
commonly affected area during breast cancer irradiation.
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severe delayed changes that follow such as dermal atro-
phy, fibrosis, retraction and susceptibility to necrosis
remain, and may affect the function and physical prop-
erties of the skin [8,9]. Acute skin complications in post-
mastectomy patients have been well studied [10-12], but
little is known about risks of long term skin complica-
tions and cosmesis of thesep a t i e n t s .T h i sf o r m st h e
basis of our study.
Long term skin complication such as fibrosis is a com-
mon late side effect of radiotherapy treatment for breast
cancer patients and is considered to be a dose-limiting
factor during the therapy. Quantitative and objective
assessment of late skin reactions is helpful for oncolo-
gists and clinicians to estimate the efficacies of radio-
therapy regimens or prediction of cosmetics outcome of
these patients
Previous studies on radiation induced skin effects have
shown that skin assessments have been either descrip-
tive or have used subjective parameters for scaling radia-
tion effects [10,11]. The visual assessments of skin
condition are carried out subjectively by the examining
physician and it is well known that the estimation of the
visible changes by different examiners can be signifi-
cantly biased [13]. While the European Organisation for
Research and Treatment of Cancer (EORTC) and Radia-
tion Therapy Oncology Group (RTOG) [14] have an ela-
borate scoring system for acute skin reactions,
evaluation of late skin changes are more descriptive, and
there is no scoring to convey the amount of edema,
indurations and fibrosis that may be present [12].
As such, a quantitative assessment and documentation
of late postradiation skin reactions are important for fol-
lowing up of PMRT patients.
Quantitative methods that have been used to monitor
skin changes following radiation therapy include direct
evaluation of the mechanical properties of irradiated
skin by the measurement of tensile strength of skin spe-
cimens or healing wound scars [15,16], measurement of
skin erythema by optical means [17-19], evaluation of
skin water content by measurement of its dielectric con-
stant [20] and examination of skin thickness by ultraso-
nic imaging [15,21]. Among the many methods, high
resolution ultrasound of the skin has proven to be a
precise and validated method used in many skin assess-
ment studies following radiotherapy [21,22]. It enables
accurate and easily reproducible determination of the
skin’s subcutaneous thickness [19] and allows real-time
examination of the skin with relatively lower cost com-
pared with other procedures such as biopsy and MRI.
Applications of ultrasound reported in dermatology
are generally based on the measurements of skin thick-
ness [23]. Such measurements have been applied to
assess various skin conditions particularly fibrosis.
Gottllober et al [24] used the change of skin thickness
as an indicator of cutaneous fibrosis in their studies on
five patients with cutaneous radiation syndrome. Huang
et al [25] also reported a significant change of skin
thickness in the head and neck region after radiotherapy
using 20 MHz ultrasound. All these studies demon-
strated the potential use of the ultrasound detection of
skin thickness in assessing the postirradiation reactions
of the skins. It is potentially helpful to use the ultrasonic
properties to characterize the irradiated skin fibrosis
because some changes of the skin structures are induced
by therapeutic irradiation.
However, few clinical data were available in the litera-
ture for documenting the ultrasonic properties of fibro-
tic skin in vivo for postmastectomy breast cancer
patients with radiation induced fibrosis. Therefore, this
study aimed to (1) measure chronic skin changes quan-
titatively using ultrasound, in patients who have gone
through postmastectomy irradiation, and (2) determine
if there is any correlation between late skin findings and
acute visible changes using the RTOG scoring criteria in
postmastectomy patients.
Materials and methods
Patients
This study utilized the records of National Healthcare
Group (NHG) from National University Hospital (NUH)
and Tan Tock Seng Hospital (TTSH), Singapore to
identify a group of female patients previously treated at
these institutions for PMRT from January 2004-December
2005. Two hundred and five patient records were iden-
tified from the database. Of these, 7 patients had
deceased, the data of 94 patients were not complete
(absence of RTOG scoring in the five weeks of treat-
ment), 26 were not contactable due to invalid addresses
or telephone numbers, 16 patients had bilateral mas-
tectomy, lumpectomy on the contra-lateral breast or
metastases and 30 patients declined to participate in the
study. This left 32 patients eligible to be invited to par-
ticipate in the study. All of those patients were of Asian
origin.
The primary criteria used to select patients from the
data obtained from NUH and TTSH included a total
mastectomy with no bilateral involvement and should
have completed full course of radiotherapy and che-
motherapy treatments. Radiotherapy dosages and RTOG
scoring were explicitly specified on the fifth treatment
of each of the five treatment weeks and six cycles of
adjuvant intravenous chemotherapy; CMF (cyclopho-
sphamide, methotrexate and 5-fluorouracil) were deliv-
ered following the radiotherapy. The contra-lateral
breast which was not irradiated was categorized as con-
trol. Patients who had lumpectomy on the nonirradiated
breast and breast reconstruction on one side or
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chest wall, either as definitive treatment or as entry/exit
dose from previous intra-thoracic malignancy radiother-
apy were excluded from the study.
This investigation was approved by the institutional
ethics review board -National Health Group (NHG)
Domain-Specific Review Board (DSRB). Patient Informa-
tion Sheet including the reasons and the details of the
study as well as an invitation to participate in the study
was mailed to the subjects. Patient’sI n f o r m e dC o n s e n t
form was signed by the patient on the same day of the
ultrasound scan, prior to the scan.
Radiation Therapy
All patients were 3D planned using 3D Xio Treatment
planning system. The patients were positioned supine
with elevated arms, flexed elbows supported by a wing-
board. A high pillow was used to support the knees to
ensure patient fixation during radiotherapy. Prior to
radiotherapy, all patients had treatment marks drawn
using a permanent marker which extended from the
second costal cartilage down to 1 cm inferior to the
contra-lateral non-irradiated breast. The medial margin
forms the midline and the lateral margin the mid-axil-
lary line (Figure 1). Three permanent tattoos were used
in the central treatment plane as a guide to reproduce
the treatment marks, when necessary.
The whole breast had been irradiated using opposed
tangential fields with 6 MV photons covering the axil-
lary and the infra-and supra-clavicular areas for all
patients. The total dose was 46-50 Gy administered in
daily doses of 2 Gy 5 days a week using a Siemens Pri-
mus, linear accelerator (Siemens Medical Systems,
USA). Wedges and bolus of 1 cm thickness were used
every day in all patients to optimize the homogeneity of
the dose distribution.
Ultrasound Measurements
To measure the skin thickness, ultrasound was performed
using a Sequoia
® 512 scanner (Siemens Medical Systems,
USA) with a linear array transducer (15L8 W). The 52
mm foot print transducer has a wide bandwidth with a 14
MHz centre frequency and can achieve a maximum depth
of 80 mm. The “Breast Detail” preset was selected to give
the settings discussed in Table 1. All the scans were per-
formed using a special magnification mode without sub-
stantial loss of resolution (RES-mode) to have clearer
details and precise measurements of the skin.
After informed consent was taken, the patients were
requested to lie supine on the couch. The treatment
field points were reproduced with the aid of the
patients’ case notes and the presence of permanent tat-
toos which had been marked in the central treatment
plane during the treatment. Nine points for ultrasonic
measurements within the medial, central and the lateral
areas of the treatment field as well as the corresponding
points in the contra-lateral non-irradiated breast were
marked as shown in Figure 2 and Figure 3.
A shadow found in the scar region can limit the ultra-
sound evaluation (Figure 4). If the measurement points
fell on the mastectomy scar, the points were marked
1cm superiorly or inferiorly to the original points. The
corresponding points were also marked on the contra-
lateral non-irradiated breast to achieve measurement
consistency.
All ultrasonic measurements were obtained using the
slightest transducer force on the skin, by ensuring the
transducer rested on the thick layer of gel to avoid affecting
Irradiated chestwall volume 
Supraclavicular volume 
Figure 1 Treatment marks on the patient.
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same sonographer to reduce inter-operator error.
The axis of the transducer was kept perpendicular to
the surface of the skin while scanning to maximize spec-
ular reflection at the skin/subcutaneous tissue interface
(Figure 6). All the points marked were individually
scanned in the transverse plane. The full skin thickness
(epidermis plus dermis) from the anterior echogenic
border of the epidermis to the posterior echogenic bor-
der of the dermis was measured in B-mode. All images
were stored in the hard-drive of the ultrasound machine
for analyses. As a reference measurement, examination
of the contra-lateral non-irradiated breast was carried
out at the same time. This was a blind study whereby
the sonographer was not aware of the retrospective col-
lected data of the RTOG acute scoring.
Statistical Analyses
T h em e a s u r e m e n t so fe a c ho ft h en i n ep o i n t so fi r r a -
diated skin were compared with corresponding points of
non-irradiated skin by using a t-test. This test deter-
mined the significance of differences between the values
of the same measurements made under the two different
conditions (postmastectomy with radiation skin thick-
ness versus non-irradiated contra-lateral skin thickness).
These measurements obtained in the radiated breast
were compared to the retrospective data of the peak
acute RTOG scoring obtained during the treatment
weeks by utilizing a t-test. A p value < 0.05 was consid-
ered significant.
Results
The median age of patients at the time of ultrasound
scan was 52.5 years (range 37 to 68 years). The median
interval between the last radiotherapy treatment and
current ultrasound scan was 27.5 months (range 16 to
39 months). The skin thickness was reduced in the irra-
diated chest wall compared to the contra-lateral non-
irradiated breast (Table 2 and Table 3). The mean total
skin thickness inclusive of the epidermis and the dermis
Table 1 Relevant Equipment Settings for the ‘Breast Detail’ preset
Power 0dB, Mechanical index = 1.6: As Low As Reasonably Achievable to minimize bio-effects.
Time Gain Compensation
(TGC)
Adjusted to compensate the effect of attenuation in the subcutaneous tissue at greater depths in order to produce
images of uniform brightness.
Dynamic Range 66 dB permits best differentiation between subtle changes in echo intensities of the skin region.
Persistence 2 used to provide optimum smoothening of images with minimum movement induced artifacts.
Post-processing Options range from low (0) to high (3) contrast. It was at 2 to obtain optimal level of contrast.
Overall Gain Set at 2dB to demonstrate tissues with appropriate brightness.
Edge +2 to emphasize the boundaries between tissues.
Delta Δ2 for high contrast resolution.
Spatial Compounding A form of frame averaging. SC1 selected to maximize frame rate.
Frame Rate Decreases with increasing the scan depth, the number of focal zones and image line density (resolution). Varies during
the scan but it should not be below 10 Hz (fps).
Focal Zone Single focal zone placed at the level of the skin to optimize lateral resolution.
Figure 2 Representation of points on the chest wall and contra-lateral non- irradiated breast.
Wong et al. Radiation Oncology 2011, 6:9
http://www.ro-journal.com/content/6/1/9
Page 4 of 10of the right irradiated side was 0.1712 mm (± 0.03392
mm) compared with the left non-irradiated breast which
was 0.1845 mm (± 0.04089 mm; p = 0.007). The left
irradiated skin had a mean skin thickness of 0.1764 mm
(± 0.03184 mm) compared with the right non-irradiated
breast which was 0.1835 mm (± 0.02584 mm; p =
0.025). These independent t-tests produced a significant
difference of reduced skin thickness on the right irra-
diated chest wall, p = 0.007 (p < 0.05) and left irradiated
chest wall r = 0.025 (p < 0.025) in comparison to the
non-irradiated skin thickness investigating chronic skin
reactions.
Skin thickness for grade 1 and grade 2 of skin toxicity
w a sc o m p a r e di nt h i ss t u d y .O t h e rg r a d e sw e r en o t
included as there was only one patient representing
grade 0 and grade 3 respectively and none of grade 4.
Patients with grade 2 acute skin toxicity presented with
thinner skin compared to patients with grade 1. The
mean skin thickness for patients who had grade 2 was
0.1720 mm (± 0.03132 mm), while for grade 1 it was
0.1879 mm (± 0.03900 mm, p = 0.006).
Measurements between irradiated and non-irradiated
breast (contra-lateral), show that the skin on the medial
aspect measured at points 1, 4 and 7 was consistently
thicker than the lateral aspect measured at the marked
points of 3, 6 and 9 (Table 4). A total of 3 points from
both medial (points 1, 4 and 7) and lateral (points 3, 6,
and 9) aspect of the breast was measured. Total N = 32
patients × 3 points (total) = 96 from each side.
Discussion
I nt h i ss t u d yw ed e m o n s t r a t e dq u a n t i t a t i v eu l t r a s o u n d
as an objective means of assessing late skin toxicity in
postmastectomy breast cancer patients after radiation
therapy. Huang et al [25] has demonstrated that skin
thickness measured via ultrasonic imaging proved to be
a reliable quantitative and noninvasive measure to pro-
vide diagnostically useful information for an in vivo
assessment of skin fibrosis. Using this as a feasible
study, skin thickness was measured as a proxy for radia-
tion induced fibrosis and edema in 32 postmastectomy
breast cancer patients who received full course of radia-
tion therapy in our department. This is one of the few
studies of its kind on postmastectomy breast cancer
patients follow up comparing late skin effects particularly
radiation induced fibrosis with acute scoring. To the best
of our knowledge, there is limited literature available
about radiation induced fibrosis after postmastectomy
radiotherapy in ultrasonic imaging. This study attempted
to provide some basic clinical results for this purpose.
Our study has shown that there is a statistically signifi-
cant difference between the skin thicknesses of the irra-
diated chest wall and the contra-lateral non-irradiated
breast and a predisposition to chronic reactions was
Figure 3 Points marked on the chest wall and contra-lateral
non-irradiated breast prior to ultrasound.
Figure 4 Scar causes shadowing.
Figure 5 Transducer resting on the thick layer of gel on the skin.
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and grade 2. These differences could assist to explain
breast reconstruction complications in postmastectomy
breast cancer patients after receiving a course of radio-
therapy. A number of studies have demonstrated an
increased rate of breast reconstruction complications
after postmastectomy radiotherapy [26-29]. Tallet et al
[29] reported breast reconstruction complications were
significantly greater in patients who received radiother-
apy than those who did not (51% vs 14%) and a study by
Behranwala et al [27] suggested that the rate of capsular
contracture due to radiation might be as high as 40%. As
such most complications were either due to capsular
contracture with or without pain, or skin fibrosis due to
radiation exposure.
In an effort to explain the increased breast reconstruc-
tion complications in patients due to increased radiation
dose to the skin, a separate pilot study (results sub-
mitted for publication) was conducted in our depart-
ment to assess skin dose in post-mastectomy radiation
measured by TLDs in a customized chestwall phantom.
The measurements were also analyzed with the use of
wedges and the presence of bolus. The surface dose
with bolus was determined to be much larger than that
without bolus as expected (39% increase in dose when
bolus was used).
In addition, results showed that the oblique incident
angle and flat chestwall thickness also played an impor-
tant factor in increasing the skin dose in postmastectomy
patients. As severity of skin toxicity is radiation-dose
related, this suggests a possible relationship with breast
reconstruction complications and an impairment of the
skin thickness with radiation due to skin fibrosis.
The accuracy of the ultrasonic measurement of skin
thickness has been established since the late 1970s [23].
By introducing this method in our study, we found that
the breast skin thickness decreased significantly in the
postmastectomy patients after radiotherapy. In our
study, the skin thickness of the postmastectomy breast
cancer patients was approximately 9.2% to 9.6% smaller
than that of the control non-irradiated side. This is in
contrast to previous publications [24,30] that reported
an increase of 37% in the neck region and 38% in the
conservatively managed breast following irradiation. One
possible reason for the discrepancies was the difference
of radiation dosage used for the patients. Another possi-
b l er e a s o nw a st h ed i f f e r e n c eo ft h ef o l l o w - u pt i m eo f
the subjects at recruitment.
Our proposed mechanism was supported by Wars-
zawski et al [30] who reported that structural changes
occurring after radiotherapy depend on the time interval
between the completion of treatment and ultrasonic
examination. Fibrosis is a common late side effect of
radiotherapy treatment for cancer patients and is con-
sidered to be a dose-limiting factor. It has been reported
that the latency of fibrosis is between 1-2 years post
radiotherapy and the severity of fibrosis progresses over
time. Usually the skin first becomes erythematous due
to desquamation (Figure 7), then thinned due to inade-
quate cell proliferation in the basal layer [31]. If damage
Figure 6 Echogenic border between the skin and the subcutaneous tissue.
Table 2 Reduced mean skin thickness on the Right mastectomy side with radiation in comparison to the Left non-
irradiated breast
STATISTICS
Side N Mean Std. Deviation Std. Error Mean
Skin thickness mm Right Mastectomy 117 .1712 .03392 .00314
Left Control 117 .1845 .04089 .00378
*The sample size N = 117 refers to the 9 measurement points taken in 13 Right Sided mastectomy patients.
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Page 6 of 10is too severe, the skin will break down and ulcerate due
to depletion of the regenerating cells in the basal layer
[32]. In a group of 106 patients with lumpectomy fol-
l o w e db yr a d i o t h e r a p yw e r ee x a m i n e db yL e u c h te ta l
using ultrasound, the time between completion of radio-
therapy and the ultrasound examination ranged from
3 weeks to 8 years [33]. Skin thickness was noted to initi-
ally increase then decrease after 2 years. Another study
reported by Calkins et al examined twenty-one breast
cancer patients who had undergone segmental resection
and radiation therapy [34]. The authors also observed an
increase in skin thickness followed by a decrease in four
of nine patients for whom serial ultrasound scans were
performed beginning one to forty eight months after
their radiation. A review of literature [34,35] have shown
that majority of patients assessed were those following
conservative surgery and irradiation.
Correlations of Acute skin scoring (RTOG) and fibrotic
skin thickness
Skin reactions occurring within a time interval of up to
three months following irradiation are defined as early
reactions and reactions presenting after three months
following irradiation are defined as late reactions [7].
There is a well-established process of visual assessment
of acute skin reactions using RTOG Scoring [35] which
is carried out subjectively by the examining physician
(Table 5). The acute toxicity analyzed in this study was
the peak score recorded during the weekly assessment
at the end of every radiotherapy treatment.
In this study, grade 1 acute skin reaction was found in
72% of patients, grade 2 in 22% of patients and grade 3
and grade 0 were found in 3% each. No patient had
grade 4 skin reaction in the study. These results are
similar to those reported in literature whereby Back [36]
demonstrated a low rate of acute toxicity with a RTOG
score of 3 and 4 which occurred in only 6% of women
receiving radiotherapy. Small and Woloschak [31] also
added that on average, more than 80% of acute skin toxi-
city during breast radiation was in the grades of 1 and 2.
In our study we correlated acute RTOG with their
measured skin thickness and demonstrated that patients
with higher grade of acute skin reactions; i.e., grade 2,
demonstrated reduced skin thickness as compared to
those patients with grade 1 reaction in table 6.
On ultrasound, the skin appears echogenic and is well
demarcated from the underlying hypoechoic subcuta-
neous fat. However, the epidermis cannot be resolved
from the dermis on ultrasound. The epidermis is com-
posed of several layers. The stratum basale is the dee-
pest layer where the majority of cell division occurs.
This layer is the most sensitive for radiation injury that
results in the clinically visible acute radiation skin reac-
tions [37].
In addition, we also looked at the variation in skin
thickness across the breast. The medial and lateral
aspects of both sides were examined symmetrically. Our
results showed that the skin on the medial aspect was
consistently thicker than the lateral aspect on both the
irradiated postmastectomy and non-irradiated side. This
reported mean thickness is similar to previous studies
by Wratten et al [38] that compared variation in skin
thickness in the conservatively managed breast. This
finding suggests a need to use the same examination
point when performing serial and comparative
examinations.
The results of this study may be limited because of
small study population and non-representation of
patients with all the grades of RTOG scoring. Our study
has a low incidence of other grades of reactions espe-
cially higher grades and thus, it was not possible to
investigate whether the higher grades (grade 3 and
Table 3 Reduced mean skin thickness on the Left mastectomy side with radiation in comparison to the Right non-
irradiated breast
STATISTICS
Side N Mean Std. Deviation Std. Error Mean
Skin thickness mm Left Mastectomy 171 .1764 .03184 .00243
Right Control 171 .1835 .02584 .00198
* The sample size N = 171 refers to the 9 measurement points taken in 19 Left Sided mastectomy patients.
Table 4 Skin thickness of points marked on the medial and lateral side
STATISTICS
Side N Mean Std. Deviation Std. Error Mean
Skin thickness on contralateral non-irradiated breast mm Medial 96 .1947 .02440 .00249
Lateral 96 .1773 .02988 .00305
Skin thickness on mastectomy irradiated side Medial 96 .1960 .03330 .00340
Lateral 96 .1669 .03716 .00379
*The sample size N = 96 refers to 3 measurement points taken from each side of the 32 patients.
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probability of thinning in the skin thickness.
It is also possible that other factors such as the age,
chemotherapy and surgery of the patients may have
influenced the results. However, Turesson et al [17] stu-
died 402 breast cancer patients who received radiother-
apy and were followed up for ten years. Prognostic
factors for acute and late skin reactions such as treat-
ment-related variables and patient-related variables were
analyzed. They could not verify that age; hemoglobin
level, smoking and collagen vascular diseases had signifi-
cant influence on the acute and late skin reactions.
High frequency ultrasound provides easy, low cost
and quantitative value in studying skin thickness in
acute and chronic skin reactions. A great attention to
the ultrasound technique must be given. It is important
to maintain the ultrasound beam perpendicular to the
surface of the skin to avoid artifacts due to scattering
and minimizing variations in pressure of the transducer
on the skin which may alter its apparent skin thick-
ness. In this study, each marked point was only mea-
sured once and may have affected the intra-rater
variability. An average measurement of two to three
times would be more representative of each of the
measured point. However, Agner et al [39] reported
that the coefficient of variation of repeated ultrasound
measurements were low (approximately 2.2% on
normal skin).
Further prospective studies are required in measuring
ultrasonic skin thickness before, during and after radio-
therapy treatment followed-up yearly after treatment for
about 10 years to document quantitative skin changes.
Warszawski et al [21] proved that the structural changes
in the assessment of early and late skin reactions can be
recorded by ultrasonic evaluation and much earlier than
visible reactions by the naked eye of the examining phy-
sicians. However, results did not demonstrate any signif-
icant difference in skin changes over long periods.
Patients requiring radiotherapy had a higher rate of
expander implant breast reconstruction failure and com-
plications to patients who did not receive RT [40]. This
can be explained in part by increased thinning of the
skin post radiotherapy which increased overall contrac-
ture failure rate and thus, adverse cosmetic outcome.
Further studies are needed to confirm this explanation
by quantifying the changes of the water and collagen in
post irradiated skin. Two directions may be considered
in future investigations to study how the severity of
fibrosis affects skin thickness. One is to conduct bio-
chemical or histological examinations directly to quan-
tify the level of skin fibrosis and the other is to measure
specifically the physical properties such as elasticity of
the skin layer, as an indicator of the cutaneous fibrosis
before and after radiation. This leads us to our next
study which looks at histological changes of human skin
cells after fractionated radiotherapy in an effort to
explain the effects of fibrosis and skin changes in post-
mastectomy radiotherapy.
Conclusion
Our study has proven that high frequency ultrasound
can be utilized to document quantitative sonographic
changes of the skin thickness in postmastectomy breast
cancer patients following radiotherapy. This study also
demonstrated a statistically significant difference in the
skin thickness between the irradiated side and the con-
tra-lateral non-irradiated breast. This finding might be
helpful to predict late skin reactions. In spite of just
using two grades of RTOG scoring in this study, a sta-
tistically significant predisposition to chronic reactions
Figure 7 Erythema and dry desquamation seen in Grade 1.
Table 5 RTOG Scoring Criteria for Acute Radiation Skin
Reactions
RTOG Scoring
Criteria
Skin Changes
0 No change over baseline
1 Follicular, faint or dull erythema, epilation, dry
desquamation, decreased sweating
2 Tender or bright erythema, patchy moist
desquamation, moderate oedema
3 Confluent, moist desquamation other than skin folds,
pitting oedema
4 Ulceration haemorrhage, necrosis
Table 6 Reduced mean skin thickness in patients with
grade 2 acute skin reactions
Group Statistics
grade N Mean Std. Deviation Std. Error Mean
Skin thickness grade 1 207 .1879 .03900 .00271
mm grade 2 63 .1720 .03132 .00426
*The sample size N = 207 refers to the 9 measurement points taken in 23
patients with Grade 1 and N = 63 refers to the 9 measurement points taken
in 7 patients with Grade 2.
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ability to successfully predict the complication risk for
individual patients can lead to real advances in radiation
oncology. These results can be used to decide which
patients would benefit from breast reconstruction and
perhaps dissuade patients whose skin is too thin and
who are likely to experience breast reconstruction fail-
ure after postmastectomy radiotherapy.
Patient’S Consent
Written informed consent was obtained from the patient
for publication of this case report and accompanying
images.
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